Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Children Often Get Antibiotics for Pink Eye, Even Though It Doesn’t Work: Study Most cases of pink eye resolve naturally without the need for antibiotic drugs, which medical experts caution are ineffective against viral conditions. July 3, 2024 Martha Garcia Add Your Comments Amid continuing concerns about the long-term impact of antibiotic overuse, which contributes to the rise of “super bug” infections that are resistant to available treatments, researchers warn that children and teens continue to receive antibiotic eye drops for conjunctivitis, commonly known as pink eye, even though drugs do not effectively treat the condition. In a study published in JAMA Ophthalmology on June 27, researchers from the University of California, San Francisco and Harvard, led by Dr. Daniel J. Shapiro, found that roughly two-thirds of kids and teens treated for pink eye were given antibiotics to treat the condition. Pink eye is a highly contagious inflammation of the eye, which affects one out of every eight U.S. children and teens each year. The condition causes the eye to become red, swollen, and itchy, and can also cause a sticky discharge. While doctors have historically prescribed antibiotic drops to treat pink eye, the American Academy of Ophthalmology (AAO) recommends against this protocol, since conjunctivitis is usually a viral infection, not bacterial, and cannot be effectively treated with antibiotics. Research suggests that treating pink eye with a cold, wet towel and artificial tears is sufficient to alleviate symptoms and let the virus resolve naturally. Furthermore, even mild bacterial eye infections typically clear up on their own without the need for medications. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Antibiotics Overused for Pink Eye In their latest study, Dr. Shapiro and his team analyzed the frequency of antibiotic prescriptions for pink eye among children and teens. They examined insurance claims data from commercially insured young patients diagnosed with acute infectious conjunctivitis across the United States in 2021. According to the data, 45,000 children received treatment for pink eye at doctor’s offices, eye clinics, or emergency rooms that year, with 69% being prescribed antibiotic drops or ointments for their condition. The study reveals that children and teens treated in doctor’s offices were more likely to receive antibiotics for pink eye (72%) compared to those seen in emergency rooms (57%) or at eye clinics (34%). Eye clinics tend to prescribe fewer antibiotics, because they have specialized diagnostic tools to identify the underlying cause of pink eye, leading to more accurate diagnoses and treatment plans. Additionally, the researchers found that fewer than 4% of all patients made return visits for pink eye, suggesting that regardless of whether antibiotics were used, most cases did not worsen or lead to complications. The data also suggests that antibiotics might not significantly improve outcomes, as there was no increased rate of return visits among those who did not receive them initially. Based on these findings, Dr. Shapiro’s team advocates for updated guidelines to reduce the frequency of antibiotic prescriptions for pink eye among children and teens. Antibiotics and the Spread of Superbugs There has been much concern over antibiotic prescribing habits in recent years, as research indicates inappropriate antibiotic prescriptions increase the risk of global superbugs, which are resistant to available antibiotics, making them very difficult to treat and potentially deadly. According to research published in the journal of Health Affairs in 2020, half of all antibiotic prescriptions are issued for conditions that are not genuine bacterial infections treatable by antibiotics. Moreover, the overuse of antibiotics in children not only increases the likelihood of side effects, such as stomach problems and yeast infections, it has also been found to increase healthcare costs. Inappropriate antibiotic prescriptions for children can result in as much as $97 in unnecessary costs per patient, accumulating to tens of millions of dollars annually for the various conditions treated. Among adults, overusing antibiotics is linked to an increased risk of early death and organ dysfunction, according to data published by researchers from the University of Michigan earlier this year. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Antibiotics, Children, Conjunctivitis, Infection, Pink Eye, Prescribing Error More Lawsuit Stories Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections December 30, 2025 Cartiva Toe Lawsuit Consolidation To Be Considered by JPML in January 2026 December 30, 2025 ByHeart Botulism Cases Taper Off, While Lawsuits and Food Safety Concerns Continue to Build December 30, 2025 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: today) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: yesterday) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025) Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
ByHeart Botulism Cases Taper Off, While Lawsuits and Food Safety Concerns Continue to Build December 30, 2025
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: today) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: yesterday) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)